3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
8
Neoplasms
4
Multiple Myeloma
3
Radiation Injuries
2
Multiple Chronic Conditions
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Esophageal Neoplasms
2
Cognitive Dysfunction
2
Brain Neoplasms
2
Substance-Related Disorders
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Pain
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mobility Limitation
1
Melanoma
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Kidney Neoplasms
1
Hyperthermia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Ultrasonic Waves
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Surveys and Questionnaires
1
Patient Reported Outcome Measures
1
Nicotine Replacement Therapy
1
Nicotine Chewing Gum
1
Ethanol
1
Educational Status
1
Dosage Forms
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Substance-Related Disorders
×
Patient Reported Outcome Measures
×
Clear all
NCT05684939
2023-06-13
CAPS
University Hospital, Clermont-Ferrand
Completed
2,010 enrolled